Cytokinetics ALS Drug Trial Fails to Meet Primary Goal

Cytokinetics said a clinical trial of its drug to treat amyotrophic lateral sclerosis, or ALS, failed to reach its primary efficacy goal, and a secondary efficacy analysis produced mixed results.



from WSJ.com: US Business http://ift.tt/1faUEwN

via IFTTT